(±)-TRAMADOL
Post-Mastectomy Chronic Pain Syndrome
Assiut UniversitySmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Post-Mastectomy Chronic Pain Syndrome cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
DEXAMETHASONE McGill University Health Centre/Research Institute of the McGill University Health Centre | Phase 4 | BB |
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE Brigham and Women's Hospital | Early Phase 1 | C |
Pregabalin Assiut University | N/A | D |
Same molecule, other indications
(±)-TRAMADOL is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →